摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,7-heptanediol dipropenoate | 61804-12-4

中文名称
——
中文别名
——
英文名称
1,7-heptanediol dipropenoate
英文别名
heptane-1,7-diyl diacrylate;7-Prop-2-enoyloxyheptyl prop-2-enoate
1,7-heptanediol dipropenoate化学式
CAS
61804-12-4
化学式
C13H20O4
mdl
——
分子量
240.299
InChiKey
CKDIBPOOPFHEAK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    110-113 °C(Press: 0.03 Torr)
  • 密度:
    1.000±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    17
  • 可旋转键数:
    12
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    1,7-heptanediol dipropenoatedisodium hydrogenphosphate双氧水三氟乙酸酐 作用下, 以 二氯甲烷异丙醇 为溶剂, 反应 51.0h, 生成 7-[3-[6,7-dimethoxy-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-2-hydroxypropanoyl]oxyheptyl 3-[6,7-dimethoxy-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-2-hydroxypropanoate
    参考文献:
    名称:
    Neuromuscular blocking agents. Some approaches to short acting compounds
    摘要:
    A series of amidic and N-methylamidic methyl and trideuteromethyl quaternary analogues of atracurium have been prepared. All were less potent and longer acting neuromuscular blocking agents than atracurium, and all showed appreciable vagal blockade at neuromuscular blocking doses. Replacement of NCH3 by NCD3 failed to affect potency. Fluorosubstitution in the central chain did not reduce duration of action. Attachment of acyloxy substituents to the interquaternary chain of atracurium and related compounds adjacent to their ester groups shortened the duration of action significantly. Diformyloxy substitution was the most effective in reducing duration without adversely affecting other properties apart from potency, which was significantly less than that of atracurium.
    DOI:
    10.1016/0223-5234(92)90180-9
  • 作为产物:
    描述:
    1,7-庚二醇丙烯酰氯三乙胺邻苯三酚 作用下, 以 为溶剂, 反应 0.5h, 以62%的产率得到1,7-heptanediol dipropenoate
    参考文献:
    名称:
    Stenlake; Waigh; Dewar, European Journal of Medicinal Chemistry, 1981, vol. 16, # 6, p. 515 - 524
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
    申请人:McDaniel C. Steven
    公开号:US20100210745A1
    公开(公告)日:2010-08-19
    Disclosed herein are polymeric materials such as a coating, a plastic, a laminate, a composite, an elastomer, an adhesive, or a sealant; a surface treatment such as a textile finish or a wax; a filler for such a polymeric material or a surface treatment that includes an enzyme such as an esterase (e.g., a lipolytic enzyme, a sulfuric ester hydrolase, an organophosphorus compound degradation enzyme), an enzyme (e.g., a lysozyme, a lytic transglycosylase) that degrades a cell wall and/or a cell membrane component, a biocidal or biostatic peotide, and/or a peptidase. Also disclosed herein are methods of altering a material's property such as service life, flexability, or rigidity, by incorporation of an enzyme into a material capable of being chemically crosslinked by the activity of a lipolytic enzyme, a hydrolase, and/or a urease.
    本文公开了一些聚合材料,如涂层、塑料、层压板、复合材料、弹性体、粘合剂或密封剂;一种表面处理,如纺织品涂层或蜡;一种填料,用于这样的聚合材料或表面处理,其中包括一种酶,如酯酶(例如,脂肪水解酶,硫酸酯水解酶,有机磷化合物降解酶),降解细胞壁和/或细胞膜成分的酶(例如,溶菌酶,裂解转糖基酶),生物杀菌或生物静态肽,以及/或肽酶。本文还公开了通过将酶纳入可通过脂肪水解酶、水解酶和/或脲酶的活性交联材料中来改变材料性能,如使用寿命、柔韧性或刚度的方法。
  • Anti-fouling Paints and Coatings
    申请人:Reactive Surfaces LTD
    公开号:US20150191607A1
    公开(公告)日:2015-07-09
    Disclosed herein are polymeric materials such as a coating, a plastic, a laminate, a composite, an elastomer, an adhesive, or a sealant; a surface treatment such as a textile finish or a wax; a filler for such a polymeric material or a surface treatment that includes an enzyme such as an esterase (e.g., a lipolytic enzyme, a sulfuric ester hydrolase, an organophosphorus compound degradation enzyme), an enzyme (e.g., a lysozyme, a lytic transglycosylase) that degrades a cell wall and/or a cell membrane component, a biocidal or biostatic peptide, and/or a peptidase. Also disclosed herein are methods of altering a material's property such as service life, flexability, or rigidity, by incorporation of an enzyme into a material capable of being chemically crosslinked by the activity of a lipolytic enzyme, a hydrolase, and/or a urease.
    本文披露了聚合材料,例如涂层、塑料、层压材料、复合材料、弹性体、粘合剂或密封剂;表面处理,例如纺织品整理或蜡;填充剂,用于这种聚合材料或表面处理,包括酯酶(例如脂肪水解酶、硫酸酯水解酶、有机磷化合物降解酶)的酶,降解细胞壁和/或细胞膜成分的酶(例如溶菌酶、裂解转葡糖苷酶),生物杀菌或生物稳定肽,和/或肽酶。本文还披露了通过将酶并入能够通过脂肪水解酶、水解酶和/或脲酶的活性进行化学交联的材料中,改变材料性能(例如使用寿命、柔韧性或刚度)的方法。
  • COMPOSITE SEMIPERMEABLE MEMBRANE AND METHOD FOR PRODUCING SAME
    申请人:Toray Industries, Inc.
    公开号:EP2650044A1
    公开(公告)日:2013-10-16
    Provided is a composite semipermeable membrane comprising a microporous support membrane and a separation functional layer formed thereon, wherein the separation functional layer is formed from Compound (A) in which a reactive group(s) having an ethylenically unsaturated group and a hydrolyzable group(s) are bonded directly to a silicon atom, Compound (B) having an ethylenically unsaturated group, the Compound (B) being different from said Compound (A), and Compound (C) having an ethylenically unsaturated group, the Compound (C) being different from said Compound (A) and (B), by condensation of hydrolyzable groups that the Compound (A) has and polymerization of ethylenically unsaturated groups that the Compound (A), the Compound (B), and the Compound (C) have, and the Compound (A), the Compound (B), and the Compound (C) satisfy the relationship of the following equation (I): QA-QC+QB-QC=QA-QB (Qx represents an Alfrey-Price Q value of Compound X). A composite semipermeable membrane having excellent chemical resistivity to chemicals represented by chlorine, separation performance, and water permeability can be provided.
    提供了一种复合半透膜,包括微孔支撑膜和在其上形成的分离功能层,其中分离功能层由以下化合物形成:化合物(A),其中具有乙烯不饱和基团的反应基团和可水解基团直接键合到硅原子上;化合物(B),具有乙烯不饱和基团,所述化合物(B)不同于所述化合物(A);以及化合物(C),具有乙烯不饱和基团,所述化合物(C)不同于所述化合物(A)和(B)、化合物(A)具有的可水解基团和化合物(A)、化合物(B)和化合物(C)具有的乙烯基不饱和基团的缩合,以及化合物(A)、化合物(B)和化合物(C)具有的乙烯基不饱和基团的聚合,以及化合物(A)、化合物(B)和化合物(C)具有的乙烯基不饱和基团的聚合,满足下式(I)的关系:QA-QC+QB-QC=QA-QB (Qx 代表化合物 X 的 Alfrey-Price Q 值)。 可以提供一种复合半透膜,它对以氯为代表的化学物质具有极佳的耐化学性、分离性能和透水性。
  • STENLAKE, J. B.;WAIGH, R. D.;DEWAR, G. H.;HUGHES, R.;CHAPPLE, D. J.;COKER+, EUR. J. MED. CHEM.-CHIM. THER., 1981, 16, N 6, 515-524
    作者:STENLAKE, J. B.、WAIGH, R. D.、DEWAR, G. H.、HUGHES, R.、CHAPPLE, D. J.、COKER+
    DOI:——
    日期:——
  • Protective coating material
    申请人:Tosoh Corporation
    公开号:EP0482557B1
    公开(公告)日:1994-06-15
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物